Internal Medicine, Pulmonary Disease · Forrest City, AR
NPI
1609096577
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
904 Holiday Dr
Forrest City, AR, 72335
Phone (870) 630-9362
Groups this clinician bills Medicare through
Medicare paid, 2024
$78K
1,291 services
Medicare patients, 2024
442
Average age 72
Drug cost, 2024
$1.3M
2,735 prescriptions
Company payments, 2025
$802
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nizar C Issa was code 99214 (office e&m - established), 419 times for 232 patients. In total Nizar C Issa billed 1,291 services in 15 codes, and Medicare paid $78K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 419 | 232 | $83.64 | $35K |
| 99213 Office E&M - Established | Office | 251 | 205 | $54.53 | $14K |
| 94060 Pulmonary Function Testing | Office | 118 | 112 | $7.33 | $865 |
| 94726 Pulmonary Function Testing | Office | 114 | 110 | $8.57 | $977 |
| 94729 Pulmonary Function Testing | Office | 114 | 110 | $6.33 | $722 |
| 99204 Office E&M - New | Office | 114 | 114 | $94.13 | $11K |
| G0008 Administration of influenza virus vaccine | Office | 33 | 33 | $29.23 | $965 |
| 90677 Vaccine Product | Office | 28 | 28 | $280.34 | $7,849 |
| G0009 Administration of pneumococcal vaccine | Office | 27 | 27 | $29.23 | $789 |
| 90662 Vaccine Product | Office | 26 | 26 | $81.06 | $2,108 |
| 95810 Sleep Study | Office | 21 | 21 | $78.95 | $1,658 |
| 99215 Office E&M - Established | Office | 12 | 11 | $124.51 | $1,494 |
By year: 2022 $89K for 1,534 services; 2023 $90K for 1,374 services; 2024 $78K for 1,291 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nizar C Issa prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 801 prescriptions and refills. In total Nizar C Issa wrote 2,735 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 801 | 1,097 | 190 | $701K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 479 | 708 | 128 | $330K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 470 | 522 | 201 | $11K |
| Breo Ellipta Fluticasone/Vilanterol | 174 | 232 | 49 | $92K |
| Fluticasone Propionate Generic | 105 | 143 | 32 | $1,437 |
| Ventolin Hfa Albuterol Sulfate | 98 | 101 | 40 | $5,722 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 97 | 157 | 28 | $73K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 72 | 87 | 13 | $54K |
| Symbicort Budesonide/Formoterol Fumarate | 59 | 84 | 20 | $19K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 46 | 54 | 11 | $5,136 |
| Montelukast Sodium Generic | 45 | 65 | 11 | $284 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 35 | 35 | 28 | $221 |
| Prednisone Generic | 32 | 33 | 19 | $84.93 |
| Zolpidem Tartrate Generic | 29 | 43 | Under 11 | $105 |
| Azithromycin Generic | 26 | 26 | 19 | $146 |
Brand drugs: 2,024 claims; generic drugs: 711 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nizar C Issa $802 ($802 in general payments such as food, travel and fees) from 9 companies. The largest payer was GlaxoSmithKline, LLC. with $197.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 15 | $197 |
| Viatris Specialty LLC | 9 | $192 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $122 |
| Harmony Biosciences LLC HRMY | 3 | $105 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $90.59 |
| Electromed, Inc. ELMD | 1 | $36.47 |
| Philips North America LLC PHG | 2 | $28.53 |
| Verona Pharma, Inc. VRNA | 1 | $15.75 |
| Insmed, Inc. INSM | 1 | $14.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.